Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Carlisle Interconnect Technologies is a designer and manufacturer of high-performance wire, cable, connectors, cable assemblies, harnesses, and related interconnect solutions. Historically operated as a business of Carlisle Companies, the company was acquired by Amphenol in 2024 and now operates as Amphenol CIT. Its products primarily serve aerospace, defense, space, industrial, test and measurement, and medical technology customers rather than developing therapeutics or clinical-stage healthcare products. In medtech, it provides medical cable and interconnect solutions for device OEMs, but it is not a biotech or pharmaceutical company. The business is commercially focused, with vertically integrated design, engineering, testing, certification, and manufacturing capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Carlisle Interconnect Technologies.